Invictus RG (Singapore)’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-619
Closed -$10K 781
2014
Q4
$10K Buy
+619
New +$8.71K 0.01% 569

Invictus RG (Singapore)'s AVNR Position: Q1 2015 in Review

Invictus RG (Singapore) sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 619 shares — an estimated $10K sold.

Invictus RG (Singapore) first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $10K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Invictus RG (Singapore) reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Invictus RG (Singapore) sold 619 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $10K.
  • Invictus RG (Singapore) first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
  • Invictus RG (Singapore)'s AVANIR PHARMACEUTICALS, INC CL A position peaked at $10K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Invictus RG (Singapore)'s 13F filing for Q1 2015, filed 15 May 2015.